Institute for Nootropic Studies

Institute for Nootropic Studies

Del

Advancement in frontiers of Neuroscience

Nootropic dipeptide noopept enhances inhibitory synaptic transmission in the hippocampus. -... 24/02/2016

Bull Exp Biol Med. 2015 Jan;158(3):349-51. doi: 10.1007/s10517-015-2759-2. Epub 2015 Jan 9.

Nootropic dipeptide noopept enhances inhibitory synaptic transmission in the hippocampus.

Povarov IS1, Kondratenko RV, Derevyagin VI, Ostrovskaya RU, Skrebitskii VG.
Author information
Abstract

Application of nootropic agent Noopept on hippocampal slices from Wistar rats enhanced the inhibitory component of total current induced by stimulation of Shaffer collaterals in CA1 pyramidal neurons, but did not affect the excitatory component. A direct correlation between the increase in the amplitude of inhibitory current and agent concentration was found. The substance did not affect the release of inhibitory transmitters from terminals in the pyramidal neurons, which indicated changes in GABAergic interneurons.
PMID: 25573367 [PubMed - indexed for MEDLINE]

http://www.ncbi.nlm.nih.gov/pubmed/25573367

Nootropic dipeptide noopept enhances inhibitory synaptic transmission in the hippocampus. -... Bull Exp Biol Med. 2015 Jan;158(3):349-51. doi: 10.1007/s10517-015-2759-2. Epub 2015 Jan 9. Research Support, Non-U.S. Gov't

Neuro-modulating effects of honokiol: a review. - PubMed - NCBI 17/12/2015

Front Neurol. 2013 Sep 11;4:130. doi: 10.3389/fneur.2013.00130. eCollection 2013.
Neuro-modulating effects of honokiol: a review.
Woodbury A1, Yu SP, Wei L, García P.
Author information
Abstract
Honokiol is a poly-phenolic compound that exerts neuroprotective properties through a variety of mechanisms. It has therapeutic potential in anxiety, pain, cerebrovascular injury, epilepsy, and cognitive disorders including Alzheimer's disease. It has been traditionally used in medical practices throughout much of Southeast Asia, but has now become more widely studied due to its pleiotropic effects. Most current research regarding this compound has focused on its chemotherapeutic properties. However, it has the potential to be an effective neuroprotective agent as well. This review summarizes what is currently known regarding the mechanisms involved in the neuroprotective and anesthetic effects of this compound and identifies potential areas for further research.
KEYWORDS:
GABA; amyloid; analgesia; honokiol; inflammatory pain; magnolol; neuroprotection; stroke
PMID: 24062717 [PubMed] PMCID: PMC3769637 Free full text

http://www.ncbi.nlm.nih.gov/pubmed/24062717

Neuro-modulating effects of honokiol: a review. - PubMed - NCBI Front Neurol. 2013 Sep 11;4:130. doi: 10.3389/fneur.2013.00130. eCollection 2013. Review

24/10/2015

Zhongguo Ying Yong Sheng Li Xue Za Zhi. 2013 Jul;29(4):298-300.

[Protective effect of oxiracetam on traumatic brain injury in rats].
[Article in Chinese]
Li JW1, Yang DJ, Chen XY, Liang HQ.
Author information
Abstract

OBJECTIVE:
To study the role of oxiracetam on traumatic brain injury in rats.
METHODS:
Thirty Wistar rats were randomly divided into 3 groups: sham operation group, model group and treatment group. Feeney method were used to establish traumatic brain injury (TBI) model in rats in model and treatment group, and rats in sham group were only broached without hydraumatic fitted. Rats in treatment group were successive administration for 21 days with oxiracetam (100 mg/kg, ig). Neurologic impairment scores were undertook after operation of 1 d, 4 d, 7 d, 14 d and 21 d, and Morris water maze test were proceeded during 15 to 19 days after operation. Average escape latency, searching time in target quadrant and number of crossing target platform in rats were recorded.
RESULTS:
Neurologic impairment scores of rats in treatment group were significantly less than those of model group after operation of 7, 14 and 21 d (P < 0.05). Average escape latency of model group were significantly higher than those of sham operation group and treatment group (P < 0.05, P < 0.01). Searching time in target quadrant and number of crossing target platform of model group were lower than those of sham operation and treatment group (P < 0.05)).
CONCLUSION:
Oxiracetam could decrease neural injury and increase ability of learning, memory and space cognition in traumatic brain injury rats.
PMID: 24175546 [PubMed - indexed for MEDLINE]

20/10/2015

Brain Inj. 1991 Oct-Dec;5(4):375-80.

Placebo-Controlled Study Of Pramiracetam In Young Males With Memory And Cognitive Problems Resulting From Head Injury And Anoxia.

McLean A Jr1, Cardenas DD, Burgess D, Gamzu E.
Author information

Abstract

The current study evaluated under double-blind placebo-controlled conditions, the safety and efficacy of 400 mg pramiracetam sulphate TID in treating memory and other cognitive problems of males who have sustained brain injuries. The results of the study indicate that subject performance in measures of memory, especially delayed recall, evidenced clinically significant improvements after the administration of pramiracetam sulphate as compared to placebo. This improvement was maintained during an 18-month open-trial period on the medication as well as during a 1-month follow-up period after the pramiracetam was discontinued.

PMID: 1786500 [PubMed - indexed for MEDLINE]

[Identification and evaluation of the neuroleptic activity of phenotropil]. - PubMed - NCBI 20/09/2015

Identification and evaluation of the neuroleptic activity of Phenotropil (Phenylpiracetam)
Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7):42-6.

..Phenotropil had no sedative action and other adverse effects. It exhibited a positive effect on exploratory behavior and motor activity, had anxiolytic and antidepressant action.

http://www.ncbi.nlm.nih.gov/pubmed/23994920

[Identification and evaluation of the neuroleptic activity of phenotropil]. - PubMed - NCBI Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(7):42-6. Comparative Study; English Abstract

[The original novel nootropic and neuroprotective agent noopept]. - PubMed - NCBI 20/09/2015

The original novel nootropic and neuroprotective agent Noopept
Eksp Klin Farmakol. 2002 Sep-Oct;65(5):66-72.

In contrast to Piracetam facilitating only the early stages of the memory process, Noopept positively influences the memory consolidation and retrieval steps as well. The new drug produces an additional selective anxiolytic action...

http://www.ncbi.nlm.nih.gov/pubmed/12596521

[The original novel nootropic and neuroprotective agent noopept]. - PubMed - NCBI Eksp Klin Farmakol. 2002 Sep-Oct;65(5):66-72. Comparative Study; English Abstract; Review

Vil du plassere din skole på toppen av Skole-listen i Copenhagen?

Klik her for at gøre krav på din sponsorerede post.

Sted

Internet side

Adresse


Blegdamsvej 3B
Copenhagen
DK-2200